Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 18651 - 18675 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Copper	Approved Investigational	LAMP3	27074	upregulated	[NSC 689534 binds to Copper] which results in increased expression of LAMP3 mRNA	3q27.1	A21749
Copper	Approved Investigational	LAMTOR3	8649	downregulated	[Disulfiram binds to Copper] which results in decreased expression of LAMTOR3 mRNA	4q23	A21750
Copper	Approved Investigational	LAMTOR3	8649	upregulated	[NSC 689534 binds to Copper] which results in increased expression of LAMTOR3 mRNA	4q23	A21749
Copper	Approved Investigational	LAPTM4B	55353	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of LAPTM4B mRNA	8q22.1	A21749
Copper	Approved Investigational	LARP6	55323	upregulated	[NSC 689534 binds to Copper] which results in increased expression of LARP6 mRNA	15q23	A21749
Copper	Approved Investigational	LARS2	23395	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of LARS2 mRNA	3p21.31	A21749
Copper	Approved Investigational	LATS2	26524	upregulated	[NSC 689534 binds to Copper] which results in increased expression of LATS2 mRNA	13q12.11	A21749
Copper	Approved Investigational	LCN2	3934	upregulated	[NSC 689534 binds to Copper] which results in increased expression of LCN2 mRNA	9q34.11	A21749
Copper	Approved Investigational	LDLR	3949	downregulated	Copper results in decreased expression of LDLR mRNA	19p13.2	A21767
Copper	Approved Investigational	LEMD2	221496	upregulated	[Disulfiram binds to Copper] which results in increased expression of LEMD2 mRNA	6p21.31	A21750
Copper	Approved Investigational	LFNG	3955	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of LFNG mRNA	7p22.3	A21749
Copper	Approved Investigational	LGALS8	3964	upregulated	[NSC 689534 binds to Copper] which results in increased expression of LGALS8 mRNA	1q43	A21749
Copper	Approved Investigational	LGR5	8549	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of LGR5 mRNA	12q21.1	A21749
Copper	Approved Investigational	LHFP	10186	upregulated	[NSC 689534 binds to Copper] which results in increased expression of LHFP mRNA	13q13.3-q14.11	A21749
Copper	Approved Investigational	LIG1	3978	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of LIG1 mRNA	19q13.33	A21749
Copper	Approved Investigational	LIMA1	51474	upregulated	[NSC 689534 binds to Copper] which results in increased expression of LIMA1 mRNA	12q13.12	A21749
Copper	Approved Investigational	LIMCH1	22998	upregulated	[Disulfiram binds to Copper] which results in increased expression of LIMCH1 mRNA	4p13	A21750
Copper	Approved Investigational	LIMCH1	22998	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of LIMCH1 mRNA	4p13	A21749
Copper	Approved Investigational	LINC00261	140828	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of LINC00261 mRNA	20p11.21	A21749
Copper	Approved Investigational	LINC00304	283860	upregulated	[NSC 689534 binds to Copper] which results in increased expression of LINC00304 mRNA	16q24.3	A21749
Copper	Approved Investigational	LINC00520	645687	upregulated	[NSC 689534 binds to Copper] which results in increased expression of LINC00520 mRNA	14q22.3	A21749
Copper	Approved Investigational	LINC01554	202299	downregulated	[Disulfiram binds to Copper] which results in decreased expression of LINC01554 mRNA	5q15	A21750
Copper	Approved Investigational	LIPA	3988	downregulated	Copper results in decreased expression of LIPA mRNA	10q23.31	A21753
Copper	Approved Investigational	LIPT1	51601	downregulated	[Disulfiram binds to Copper] which results in decreased expression of LIPT1 mRNA	2q11.2	A21750
Copper	Approved Investigational	LITAF	9516	upregulated	Copper results in increased expression of LITAF mRNA	16p13.13	A21759

Displaying entries 18651 - 18675 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability